Moolec Science SA Stock (NASDAQ:MLEC)
Previous Close
$0.83
52W Range
$0.75 - $3.25
50D Avg
$0.87
200D Avg
$1.17
Market Cap
$33.44M
Avg Vol (3M)
$22.57K
Beta
-0.54
Div Yield
-
MLEC Company Profile
Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.
MLEC Performance
Peer Comparison
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| CNTA | Centessa Pharmaceuticals plc |
| MLYS | Mineralys Therapeutics, Inc. |
| CVKD | Cadrenal Therapeutics, Inc. Common Stock |
| IPSC | Century Therapeutics, Inc. |
| GBIO | Generation Bio Co. |
| LYEL | Lyell Immunopharma, Inc. |
| JANX | Janux Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| GPCR | Structure Therapeutics Inc. |
| INDP | Indaptus Therapeutics, Inc. |
| TPST | Tempest Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| FBRX | Forte Biosciences, Inc. |
| STTK | Shattuck Labs, Inc. |